History

December 2010: Opening of the brand new Proton Therapy Center after a 5 year renovation program.

November 2006: The Institut Curie officially launched an ambitious program to extend its cancer treatment capacity, as the Board of Governors awarded the contract for the extension of the Proton Therapy Center to IBA/Besix.

May 2006: First child was treated by proton therapy under general anesthesia at the Institut Curie's Proton Therapy Center (Orsay). The Proton Therapy Center is fully equipped for anesthesia and pediatric intensive care, so young patients can be treated in France rather than having to seek treatment abroad.

2005: Launch of an ambitious renovation program designed to double the number of patients treated by the year 2010.

1 January 2004: The Orsay Proton Therapy Center was attached to the Institut Curie and became the Institut Curie's Proton Therapy Center-Orsay.

Late 2003: With over 3000 patients treated, the Orsay Proton Therapy Center became the world's third largest proton therapy center for intracranial tumors, and first in Europe alongside the Institut Paul-Scherrer (Switzerland).

June 1994: First intracranial treatment at the Orsay Proton Therapy Center.

April 1991: First ophthalmological treatment at the Orsay Proton Therapy Center.

January 1991: Creation of the Orsay Proton Therapy Center (CPO), a hospital unit with exclusive use of the synchrocyclotron, under the auspices of a consortium comprising the Institut Curie, the Institut Gustave-Roussy (Villejuif), the Centre René-Huguenin (Saint-Cloud) and the Paris Public Hospitals (AP-HP).

1987: First experiments with the proton beam to assess its utilization in the treatment of cancer.

1975-1977: The synchrocyclotron was completely renovated (SC200) by the Orsay Nuclear Physics Institute (IN2P3/CNRS). In particular, its initial energy of 156 MeV was raised to 201 MeV, thus increasing its penetrative power and hence leading on to new lines of research.

1954: Irène Joliot-Curie, the director of the Research Section at the Radium Institut, which was later to become the Institut Curie, took the initiative to urge the Paris Faculty of Sciences to order a particle accelerator for the Paris-Sud University Campus. This synchrocyclotron, built by Philips (Netherlands), was intended for research in nuclear physics.

Author / Source : Proton Therapy Center